Gary is the Founder and Chairman of Inpharmation – a company that provides a host of unique, evidence-based research techniques for pricing, forecasting, and market researching pharmaceuticals.
Gary has worked with all the world’s leading pharma companies. He has a host of awards for his conference papers and his writing. His books on pharmaceutical pricing, forecasting, and market research are read and referred to by pharma executives around the world.
He has trained thousands of pharma executives how to forecast and price pharmaceuticals.
Prior to founding Inpharmation, Gary held senior positions – including country manager and head of global marketing – in major pharma companies. He has degrees in medicine and management. He is a Sloan Fellow of London Business School and a Fellow of the Royal Society of Medicine.